Placebo-Controlled Trial of an Oral Caspase Inhibitor in Patients with Decompensated Non-Alcoholic Steatohepatitis (NASH) Cirrhosis

August 22, 2018
https://clinicaltrials.gov/ct2/show/NCT03205345
Gastroenterology Hepatology
Principal Investigator: Kimberly A Brown, MD
cirrhosis, NASH, NASH Cirrhosis, nonalcoholic steatohepatitis, Non-Alcoholic Steatohepatitis, nash, Decompensated Non-Alcoholic Steatohepatitis, Cirrhosis
Open